Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Clinical trial NCT05701007 · COMPLETED

Trial details

NCT number: NCT05701007
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Castration Sensitive Prostate Cancer (mCSPC)Metastatic Castration Resistant Prostate Cancer (mCRPC)

Start date: 2023-02-13
Primary completion: 2024-04-10
Enrollment: 1083

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.